Publications
Detailed Information
Control of fluid balance guided by body composition monitoring in patients on peritoneal dialysis (COMPASS): study protocol for a randomized controlled trial
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Baek, Seon Ha | - |
dc.contributor.author | Oh, Kook-Hwan | - |
dc.contributor.author | Kim, Sejoong | - |
dc.contributor.author | Kim, Dong Ki | - |
dc.contributor.author | Joo, Kwon-Wook | - |
dc.contributor.author | Oh, Yun Kyu | - |
dc.contributor.author | Han, Byoung Geun | - |
dc.contributor.author | Chang, Jae Hyun | - |
dc.contributor.author | Chung, Wookyung | - |
dc.contributor.author | Kim, Yon Su | - |
dc.contributor.author | Na, Ki Young | - |
dc.date.accessioned | 2024-08-08T01:41:34Z | - |
dc.date.available | 2024-08-08T01:41:34Z | - |
dc.date.created | 2021-04-26 | - |
dc.date.created | 2021-04-26 | - |
dc.date.issued | 2014-11 | - |
dc.identifier.citation | Trials, Vol.15 No.1, p. 432 | - |
dc.identifier.issn | 1745-6215 | - |
dc.identifier.uri | https://hdl.handle.net/10371/207345 | - |
dc.description.abstract | Background: The clinical benefits of bioimpedance spectroscopy (BIS)-guided fluid management in patients on hemodialysis have been widely demonstrated. However, no previous reports have evaluated the effect of regular and serial BIS-guided fluid management on the residual renal function (RRF) in patients on peritoneal dialysis (PD). Therefore, we will evaluate the clinical efficacy of BIS-guided fluid management for preserving RRF and protecting cardiovascular events in patients on PD. Methods/design: This is a multicenter, prospective, randomized controlled trial. A total of 138 participants on PD will be enrolled and randomly assigned to receive either BIS-guided fluid management or fluid management based only on the clinical information for 1 year. The primary outcome is the change in the glomerular filtration rate (GFR) between months 0 and 12 after starting treatment. The secondary outcomes will include GFR at month 12, time to the anuric state (urine volume < 100 ml/day), and fatal and nonfatal cardiovascular events during treatment. Discussion: This is the first clinical trial to investigate the effect of BIS-guided fluid management on RRF and for protecting against cardiovascular events in patients on PD. | - |
dc.language | 영어 | - |
dc.publisher | BioMed Central | - |
dc.title | Control of fluid balance guided by body composition monitoring in patients on peritoneal dialysis (COMPASS): study protocol for a randomized controlled trial | - |
dc.type | Article | - |
dc.identifier.doi | 10.1186/1745-6215-15-432 | - |
dc.citation.journaltitle | Trials | - |
dc.identifier.wosid | 000345715700001 | - |
dc.identifier.scopusid | 2-s2.0-84920855688 | - |
dc.citation.number | 1 | - |
dc.citation.startpage | 432 | - |
dc.citation.volume | 15 | - |
dc.description.isOpenAccess | Y | - |
dc.contributor.affiliatedAuthor | Kim, Dong Ki | - |
dc.contributor.affiliatedAuthor | Joo, Kwon-Wook | - |
dc.contributor.affiliatedAuthor | Oh, Yun Kyu | - |
dc.contributor.affiliatedAuthor | Kim, Yon Su | - |
dc.contributor.affiliatedAuthor | Na, Ki Young | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.subject.keywordPlus | RESIDUAL RENAL-FUNCTION | - |
dc.subject.keywordPlus | EXTRACELLULAR VOLUME EXPANSION | - |
dc.subject.keywordPlus | BIOIMPEDANCE SPECTROSCOPY | - |
dc.subject.keywordPlus | HEMODIALYSIS-PATIENTS | - |
dc.subject.keywordPlus | MULTIFREQUENCY BIOIMPEDANCE | - |
dc.subject.keywordPlus | CAPD PATIENTS | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordPlus | PARAMETERS | - |
dc.subject.keywordPlus | PREDICTOR | - |
dc.subject.keywordAuthor | Fluid balance | - |
dc.subject.keywordAuthor | Bioimpedance spectroscopy | - |
dc.subject.keywordAuthor | Peritoneal dialysis | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.